Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | October 26, 2012 | October 26, 2012 |
| CHEVRON CORPCVX · Entity 2804 | Director | March 02, 2015 | March 04, 2015 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date October 26, 2012 · Filed October 26, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectLiving Trust | 4,074 |
Reported balance
After 2012-10-26 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2012-10-26 · Gift · Disposed 1,420 · Balance 4,074 |
| Common StockSEC Table I · non-derivative | IndirectLiving Trust | 0 |
Reported balance
After 2012-10-26 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2012-10-26 · Gift · Disposed 4,074 · Balance 0 |
| Common StockSEC Table I · non-derivative | Direct | 101,018 |
Reported balance
Holding disclosure · report date 2012-10-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 101,018 F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,250 RSUs which fully vest on 4/28/2013; 22,750 RSUs which vest in two equal annual installments of 11,375 each commencing 4/26/2013; 60,000 RSUs which vest in two equal installments of 19,800 each on 4/25/2013 and 4/25/2014 and one installment of 20,400 on 4/25/2015; and 8,933 RSUs which vest in three installments of 2,947, 2,948 and 3,038 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. F2: These shares include 85 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 4,433.6295 |
Reported balance
Holding disclosure · report date 2012-10-26 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 4,433.6295 F3: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,250 RSUs which fully vest on 4/28/2013; 22,750 RSUs which vest in two equal annual installments of 11,375 each commencing 4/26/2013; 60,000 RSUs which vest in two equal installments of 19,800 each on 4/25/2013 and 4/25/2014 and one installment of 20,400 on 4/25/2015; and 8,933 RSUs which vest in three installments of 2,947, 2,948 and 3,038 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.
F2: These shares include 85 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
CHEVRON CORP
Report date March 02, 2015 · Filed March 04, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 11,483 |
Reported balance
After 2015-03-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2015-03-02 · Other · Acquired 354 · Balance 11,483 F1: The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in common stock upon the reporting person's termination of service. F2: 1-for-1. F3: This number includes dividend equivalent accruals (109) under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in common stock upon the reporting person's termination of service.
F2: 1-for-1.
F3: This number includes dividend equivalent accruals (109) under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 62 | $81.49 | $5,052.38 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 11 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,268 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 103 | $81.48 | $8,392.44 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 10 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,330 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,638 | $81.47 | $214,918.65 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 9 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,433 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $81.46 | $16,292.00 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 8 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,071 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,397 | $81.44 | $195,223.43 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 7 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,271 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $81.44 | $81,443.00 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 6 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,668 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $81.42 | $16,284.00 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 5 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,668 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,300 | $81.40 | $187,223.91 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 4 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,868 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,066 | $81.40 | $168,175.50 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 3 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,168 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 34 | $81.40 | $2,767.60 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,234 Read SEC document |
| July 28, 2005 Filed Aug 1, 2005 20:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,200 | $81.37 | $179,012.90 |
DisclosureSEC source: 0001181431-05-043299 · rrd87660.xml · nonDerivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,268 Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 13 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,159 Underlying: Common Stock · 4,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 22,358 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 12 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,358 shares Expires 2006-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 2,608 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 11 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: Common Stock · 2,608 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 1,642 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 10 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,642 shares Expires 2006-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 3,052 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 9 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,052 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 3,224.201 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 8 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 3,224.201 F3 · balance_after: (KWS 401(k)) These are units acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 33,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 7 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · Living Trust Disclosed balance after: 66,751 F1 · shares: (KWS 4.29.05) Transfer of shares into reporting person's living trust. F2 · balance_after: (KWS 2.14.05) The amount of the Company's Common Stock beneficially owned has been adjusted to reflect an acquisition by the reporting person of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(1)(k)(B) and subsequent transfer of such shares to reporting person's living trust. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 33,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 6 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: (KWS 4.29.05) Transfer of shares into reporting person's living trust. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 4,000 | $38.36 | $153,440.00 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 5 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 22,358 | $30.44 | $680,521.63 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 4 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,608 | $38.36 | $100,042.88 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 3 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,642 | $30.44 | $49,978.38 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2005 Filed May 3, 2005 16:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 3,052 | $16.38 | $49,976.50 |
DisclosureSEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 00:46 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017351 · rrd72672.xml · derivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2012-03-15 F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006. Read SEC document |
| February 10, 2005 Filed Feb 16, 2005 21:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 19,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-010462 · rrd68738.xml · nonDerivative · entry 4 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · Living Trust Disclosed balance after: 33,091 F2 · kind: (KWS 2.10.05) These shares previously reported as being indirectly held by the reporting person's family trust is being transferred to the reporting person's living trust. F3 · balance_after: (KWS 2.14.05) The amount of the Company's Common Stock beneficially owned has been adjusted to reflect an acquisition by the reporting person of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and subsequent transfer of such shares to reporting person's living trust. Read SEC document |
| February 10, 2005 Filed Feb 16, 2005 21:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 13,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-010462 · rrd68738.xml · nonDerivative · entry 3 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · Living Trust Disclosed balance after: 13,789 F1 · kind: (KWS 2.05) These shares previously reported as being directly held by the reporting person is being transferred to the reporting person's living trust. F3 · balance_after: (KWS 2.14.05) The amount of the Company's Common Stock beneficially owned has been adjusted to reflect an acquisition by the reporting person of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and subsequent transfer of such shares to reporting person's living trust. Read SEC document |
| February 10, 2005 Filed Feb 16, 2005 21:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 19,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-010462 · rrd68738.xml · nonDerivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 F2 · kind: (KWS 2.10.05) These shares previously reported as being indirectly held by the reporting person's family trust is being transferred to the reporting person's living trust. Read SEC document |
| February 10, 2005 Filed Feb 16, 2005 21:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 13,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-010462 · rrd68738.xml · nonDerivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: (KWS 2.05) These shares previously reported as being directly held by the reporting person is being transferred to the reporting person's living trust. Read SEC document |
| June 18, 2004 Filed Jun 21, 2004 15:24 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 3,534 | $0.00 Strike: $14.14 | $0.00 |
DisclosureSEC source: 0001181431-04-031494 · rrd45816.xml · derivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,534 shares Expires 2004-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2004 Filed Jun 21, 2004 15:24 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 3,534 | $14.14 | $49,973.23 |
DisclosureSEC source: 0001181431-04-031494 · rrd45816.xml · nonDerivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (KWS 06.18.04) Does not include 19,302 shares indirectly held by the Family Trust. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:37 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 221,639 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015976 · rrd36784.xml · derivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,639 Underlying: Common Stock · 221,639 shares Expires 2011-03-15 F2 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:37 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 3,361 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015976 · rrd36784.xml · derivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,361 Underlying: Common Stock · 3,361 shares Expires 2011-03-15 F1 · derivative.exercise_date: (KWS 3.15.04) The option is exercisable on March 15, 2005 for 839 shares on March 15, 2006 for 841 shares: and on March 15, 2009 for 1,681 shares. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.69 | $23,476.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 30 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,804 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.75 | $23,500.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 29 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,204 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 800 | $58.62 | $46,896.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 28 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,604 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.68 | $23,472.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 27 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,404 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.72 | $23,488.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 26 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,804 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 500 | $58.94 | $29,470.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 25 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,204 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 800 | $58.70 | $46,960.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 24 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,704 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.66 | $23,464.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 23 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,504 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 800 | $58.60 | $46,880.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 22 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,904 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.64 | $23,456.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 21 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,704 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.74 | $23,496.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 20 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,104 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 800 | $58.76 | $47,008.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 19 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,504 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.50 | $23,400.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 18 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,304 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,200 | $58.54 | $70,248.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 17 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,704 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.53 | $23,412.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 16 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,904 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $58.45 | $23,380.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 15 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,304 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,600 | $58.48 | $93,568.00 |
DisclosureSEC source: 0001181431-03-031439 · rrd22979.xml · nonDerivative · entry 14 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,704 F1 · balance_after: (KWS 11/03) Does not include 48,615 shares indirectly held by the Family Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.